Experimental models of Huntington's disease

被引:9
|
作者
Garcia-Ramos, R.
del Val-Fernandez, J.
Catalan-Alonso, M. J.
Barcia-Albacar, J. A.
Matias-Guiu, J.
机构
[1] Hosp Clin San Carlos, Unidad Trastornos Movimiento, E-28040 Madrid, Spain
[2] Hosp Clin San Carlos, Serv Neurocirugia, E-28040 Madrid, Spain
[3] Hosp Clin San Carlos, Inst Neurociencias, E-28040 Madrid, Spain
关键词
3-nitropropionic acid; cellular models; excitotoxic models; Huntington's disease; quinolinic acid; Transgenic mice;
D O I
10.33588/rn.4507.2007238
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Huntington's disease (HD) is an autosomal dominant hereditary disease caused by triplet repetition in exon I of the huntingtin protein located in chromosome 4. Medium spiny neurons in the striatum are selectively affected. Clinical manifestations include progressive behavioural, motor and cognitive disorders. There is no treatment available today capable of modifying the natural course of the disease. A great amount of research work is being carried out, much of which involves animal models of the disease. Development. We reviewed the articles published in PubMed on basic research into HD and analysed the most frequently used models. Transgenic mouse models, excitotoxic models, transgenic fly models and cell cultures are all used in studies into HD. The advantages and disadvantages of each of them are highlighted. Conclusion. The contribution made by each model of HD must be known in order to draw up a correct design in experimental studies of the disease. [REV NEUROL 2007; 45: 437-41]
引用
收藏
页码:437 / 441
页数:5
相关论文
共 50 条
  • [31] Gait dynamics in mouse models of Parkinson's disease and Huntington's disease
    Amende I.
    Kale A.
    McCue S.
    Glazier S.
    Morgan J.P.
    Hampton T.G.
    Journal of NeuroEngineering and Rehabilitation, 2 (1)
  • [32] Glycation potentiates neurodegeneration in models of Huntington's disease
    Vicente Miranda, Hugo
    Gomes, Marcos Antonio
    Branco-Santos, Joana
    Breda, Carlo
    Lazaro, Diana F.
    Lopes, Lusa Vaqueiro
    Herrera, Federico
    Giorgini, Flaviano
    Outeiro, Tiago Fleming
    SCIENTIFIC REPORTS, 2016, 6
  • [33] GLYCATION POTENTIATES NEURODEGENERATION IN MODELS OF HUNTINGTON'S DISEASE
    Outeiro, Tiago Fleming
    Miranda, Hugo V.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A11 - A11
  • [34] Altered microRNA regulation in Huntington's disease models
    Lee, Soon-Tae
    Chu, Kon
    Im, Woo-Seok
    Yoon, Hye-Jin
    Im, Ji-Yeon
    Park, Jung-Eun
    Park, Ki-Ho
    Jung, Keun-Hwa
    Lee, Sang Kun
    Kim, Manho
    Roh, Jae-Kyu
    EXPERIMENTAL NEUROLOGY, 2011, 227 (01) : 172 - 179
  • [35] Knock-in mouse models of Huntington's disease
    Menalled L.B.
    NeuroRX, 2005, 2 (3): : 465 - 470
  • [36] Transgenic mouse models for Huntington's disease.
    Reddy, PH
    Williams, M
    Miller, G
    Glass, M
    Paylor, R
    Garrett, L
    Herkenham, M
    Crawley, J
    Tagle, DA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A52 - A52
  • [37] Lessons from animal models of Huntington's disease
    Rubinsztein, DC
    TRENDS IN GENETICS, 2002, 18 (04) : 202 - 209
  • [38] Large animal models for Huntington's disease research
    Bofeng Han
    Weien Liang
    Xiao-Jiang Li
    Shihua Li
    Sen Yan
    Zhuchi Tu
    Zoological Research, 2024, (02) : 275 - 283
  • [39] Glycation potentiates neurodegeneration in models of Huntington’s disease
    Hugo Vicente Miranda
    Marcos António Gomes
    Joana Branco-Santos
    Carlo Breda
    Diana F. Lázaro
    Luísa Vaqueiro Lopes
    Federico Herrera
    Flaviano Giorgini
    Tiago Fleming Outeiro
    Scientific Reports, 6
  • [40] MINIPIG MODELS OF HUNTINGTON'S DISEASE AT PIGMOD CENTER
    Vochozkova, Petra Runa
    Auch, Hannah
    Nemesh, Kateryna
    Nyguen, The Duong
    Sekac, David
    Kamenna, Eva
    Baxa, Monika
    Klima, Jiri
    Ardan, Taras
    Juhas, Stefan
    Levinska, Bozena
    Juhasova, Jana
    Keller, Jiri
    Klempir, Jiri
    Motlik, Jan
    Klymiuk, Nikolai
    Ellederova, Zdenka
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A16 - A16